An evaluation of a new chemotherapeutic strategy: Exogenous mutant PARP-1 expression sensitizes pancreatic cancer cells to clinically available platinum-based agents

Authors

Publication/Presentation Date

9-2009

Volume

209

Issue

3

First Page

53

Last Page

53

Disciplines

Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods

Department(s)

Administration and Leadership

Document Type

Article

Share

COinS